LAZYDAYS AND GENERAL RV COMPLETE FT. PIERCE, FLORIDA TRANSACTION
TAMPA, Fla., June 6, 2025 /PRNewswire/ -- Lazydays Holdings, Inc. (NASDAQCM: GORV) ("Lazydays" or the "Company") announced today that it has closed on the asset sale and real estate sale of its Ft. Pierce, Florida location to General R.V. Center, Inc. ("General RV"). The companies expect to complete the remaining divestiture in Longmont, Colorado in the coming weeks.
"We have truly appreciated the work and cooperation demonstrated by the Lazydays team to help us expand our ability to provide premier service to our Fort Pierce customers," said General RV CEO and third-generation family owner Loren Baidas. "When we opened our existing Fort Pierce Supercenter in 2023, we never stopped looking for ways to make it even better for our current and future customers. This acquisition does just that with a large Supercenter facility and easily accessible location on I-95."
Ron Fleming, Interim CEO of Lazydays, said, "We have completed our second previously announced sale of our location in Ft. Pierce, Florida to General RV. The closing of the Ft. Pierce sale continues to streamline our operations and right size our dealership footprint, while paying off meaningful debt on our balance sheet and bringing cash to our balance sheet. We are again pleased with the smooth process and look forward to working with General RV to complete the last remaining divestiture."
In the past three years, General RV has nearly doubled its number of Supercenters nationwide offering sales and service of thousands of RVs ranging from affordable travel trailers to luxury motorhomes. The third-generation family-owned company currently has more than 20 locations in nine states including Florida, Illinois, Ohio, Virginia, Utah, North Carolina, Pennsylvania, Arizona and Michigan, where its corporate offices are located. The most recent addition to the General RV family is the Mesa, Arizona location acquired in May 2025.
About Lazydays
Lazydays has been a prominent player in the RV industry since our inception in 1976, earning a stellar reputation for delivering exceptional RV sales, service, and ownership experiences. Our commitment to excellence has led to enduring relationships with RVers and their families who rely on us for all of their RV needs.
Our wide selection of RV brands from top manufacturers, state-of-the-art service facilities, and an extensive range of accessories and parts ensure that Lazydays is the go-to destination for RV enthusiasts seeking everything they need for their journeys on the road. Whether you're a seasoned RVer or just starting your adventure, our dedicated team is here to provide outstanding support and guidance, making your RV lifestyle truly extraordinary.
Lazydays is a publicly listed company on the Nasdaq stock exchange under the ticker "GORV."
About General RV
Founded in Michigan in 1962, General RV Center is the nation's premier RV dealer. The company operates more than 20 full-service dealerships in Michigan, Illinois, Ohio, Virginia, Florida, Utah, North Carolina, Arizona and Pennsylvania. Each location offers the largest selection of RVs for sale, state-of-the-art RV service facilities and retail RV parts and accessories. Visit GeneralRV.com for more information.
Forward Looking Statements
This press release includes "forward-looking statements" within the meaning of the "Safe-Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward looking statements include statements regarding our goals, plans, projections and guidance regarding our financial position, results of operations, market position, pending and potential future financing transactions and business strategy, and often contain words such as "project," "outlook," "expect," "anticipate," "intend," "plan," "believe," "estimate," "may," "seek," "would," "should," "likely," "goal," "strategy," "future," "maintain," "continue," "remain," "target" or "will" and similar references to future periods. Examples of forward-looking statements in this press release include, among others, the benefits of the potential transaction described herein and the future financial performance of the Company following such transaction.
By their nature, forward-looking statements involve risks and uncertainties because they relate to events that depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity and development of the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements in this press release. The risks and uncertainties that could cause actual results to differ materially from estimated or projected results include, without limitation, the ability of the parties to successfully close future transactions referenced herein (i.e. the sale of our Longmont, Colorado dealership assets), future economic and financial conditions (both nationally and locally), changes in customer demand, our relationship with, and the financial and operational stability of, vehicle manufacturers and other suppliers, risks associated with our indebtedness (including our ability to obtain further waivers or amendments to credit agreements, the actions or inactions of our lenders, available borrowing capacity, our compliance with financial covenants and our ability to refinance or repay indebtedness on terms acceptable to us), acts of God or other incidents which may adversely impact our operations and financial performance, government regulations, legislation and others set forth throughout under the headers "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" and in the notes to our financial statements, in our most recent Quarterly Report on Form 10-Q, Annual Report on Form 10-K and from time to time in our other filings with the U.S. Securities and Exchange Commission. We urge you to carefully consider this information and not place undue reliance on forward-looking statements. We undertake no duty to update our forward-looking statements, which are made as of the date of this release.
Contactinvestors@lazydays.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/lazydays-and-general-rv-complete-ft-pierce-florida-transaction-302475677.html
SOURCE Lazydays RV
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
U.S. Court of Appeals for the Federal Circuit Affirms Prior Delaware District Court Rulings in Favor of Acadia in NUPLAZID® (pimavanserin) Composition of Matter Patent
- Composition of matter patent affirmed, provides protection into 2030 - Builds on recent ruling in favor of Acadia for formulation patent expiring in 2038 SAN DIEGO, June 09, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. Court of Appeals for the Federal Circuit affirmed a decision issued by the U.S. District Court for the District of Delaware in December 2023 confirming validity of the NUPLAZID® (pimavanserin) '740 composition of matter patent. The affirmance came in Acadia's litigation against MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals, Inc. In its affirmance, the Appeals Court applied the precedent established in Allergan USA, Inc. v. MSN Laboratories Private Ltd., MSN Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, holding that "a first filed, first-issued, later-expiring claim cannot be invalidated by a later-filed, later-issued, earlier-expiring reference claim having a common priority date." "We are gratified that the U.S. Federal Appeals Court has affirmed the lower court's ruling in favor of our composition of matter patent for NUPLAZID, securing protection into 2030 for this patent, and beyond based on the recent favorable ruling for our formulation patent providing patent protection for NUPLAZID 34 mg capsule formulation into 2038," said Catherine Owen Adams, Chief Executive Officer. "These decisions reinforce our commitment to safeguarding the intellectual property that underpins our innovations in addressing serious, unmet medical needs." This follows the U.S. District Court for the District of Delaware ruling in favor of Acadia regarding its '721 formulation patent for NUPLAZID which ruled in favor of Acadia on both infringement and validity arguments in its formulation patent litigation against Aurobindo Pharma Limited and other ANDA (Abbreviated New Drug Application) filers. About Acadia Pharmaceuticals Acadia is advancing breakthroughs in neuroscience to elevate life. Since our founding we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson's disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuroscience and neuro-rare diseases. For more information, visit us at and follow us on LinkedIn and X. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements other than statements of historical fact and can be identified by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "predicts," "potential," "continue" and similar expressions (including the negative thereof) intended to identify forward-looking statements. Forward-looking statements contained in this press release, include, but are not limited to, statements about: (i) the impact of the court ruling on our business and our ability to defend ourselves in the future; (ii) the continued patent protection for NUPLAZID; and (iii) the anticipated timing for termination of such protections. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to: our ability to maintain, protect and enhance our intellectual property; the outcome of other existing and potential future lawsuits challenging our intellectual property; and our ability to continue to stay in compliance with applicable laws and regulations. Given the risks and uncertainties, you should not place undue reliance on these forward-looking statements. For a discussion of these and other risks, uncertainties and other factors that may cause our actual results, performance or achievements to differ, please refer to our annual report on Form 10-Q for the quarter ended March 31, 2025 as well as our subsequent filings with the Securities and Exchange Commission from time to time. The forward-looking statements contained herein are made as of the date hereof, and we undertake no obligation to update them after this date, except as required by law. View source version on Contacts Investor Contacts: Acadia Pharmaceuticals Kildani(858) 261-2872ir@ Acadia Pharmaceuticals Tieszen(858) 261-2950ir@ Media Contact: Acadia Pharmaceuticals Kazenelson(818) 395-3043media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
Inflation Cools, Jobs Steady--Is This the Market Rebound Investors Have Been Waiting For?
Consumer anxiety about rising prices may finally be easingand the timing could matter. According to fresh data from the New York Fed, Americans now see inflation coming in lower than they did just a month ago. Median year-ahead expectations dropped to 3.2% in May, down from 3.6% in April. Three- and five-year views also edged lower, now sitting at 3.0% and 2.6%, respectively. The shift follows a temporary de-escalation in trade tensions, with President Trump agreeing to reduce tariffs on Chinese imports. That announcement, while short-term, may have helped reverse the negative consumer sentiment that had been building since early this year. The job picture isn't boomingbut it might be stabilizing. Americans' perceived risk of losing their job over the next year ticked slightly lower, and more people say they feel confident enough to quit voluntarily. That's typically a positive signal for labor markets. At the same time, the share of households saying they expect to be financially worse off in a year has shrunk, and fewer respondents report difficulty accessing credit. Perhaps more telling: the average probability of missing a loan payment has dropped to its lowest point since Januaryhinting at some relief from financial stress, even as parts of the economy remain under pressure. This shift in sentiment may be influencing how people see the market. More consumers now expect the U.S. stock market to be higher a year from now. That optimism, combined with cooler inflation expectations and fewer job fears, could support short-term risk appetite heading into the summer. The Federal Reserve is widely expected to keep rates on pause at its upcoming June 1718 meeting, giving markets more room to digest the macro shifts. Tesla (NASDAQ:TSLA) and other high-beta names might see increased investor interest if this rebound in consumer confidence translates into steadier flows into equities. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
See the Incredible Returns If You Invested in 10 of the Top Performing Stocks Over the Last 5 Years (Including GameStop)
Volatility is no fun if you're a stock market investor — and there's been plenty of that so far in 2025. But it's important to keep in mind that stocks in general have always produced strong returns over time. The S&P 500 has risen by about 91% over the past five years alone, despite major headwinds ranging from COVID-19 and soaring inflation to President Donald Trump's current tariff threats. The Dow is up about 62% over the same time frame, while the Nasdaq has roughly doubled in value. Discover More: Find Out: Those are all very good returns, but they pale in comparison to the best performing stocks. If you were fortunate enough to invest in one of those, you would have seen your money rise more than 10-fold in the last half-decade. One reason some of the best performers rose so fast is that they traded at very low values five years ago — in some cases around $1 a share. Any spike in value would represent a major percentage gain. An example is GameStop, the gaming and entertainment company whose stock could be purchased for a little more than $1 a share in June 2020. GameStop grabbed headlines in early 2021 when professional investors shorted the stock, figuring it would go down in value. But as EBSCO noted at the time, a 'wave' of amateur investors started buying up shares and helped the stock soar by more than 1,500% in a matter of weeks. Today, GameStop trades for around $30 a share. If you had invested $100 in the company in early June of 2020, your investment would now be worth more than $2,500. Here's a look at the massive returns you would have gotten by investing in 10 of the top performing stocks over the past five years. Each has risen by at least 1,000% and boasts a current price of roughly $30 a share or more. Trending Now: Closing price June 8, 2020: $3.10 per share Closing price June 4, 2020: $132.41 5-year return: 4,171% Closing price June 8, 2020: $1.25 Closing price June 4, 2020: $44.97 5-year return: 3,498% Closing price June 8, 2020: $11.80 Closing price June 4, 2020: $378.10 5-year return: 3,104% Closing price June 8, 2020: $1.18 Closing price June 4, 2020: $29.95 5-year return: 2,438% Closing price June 8, 2020: $3.97 Closing price June 4, 2020: $84.89 5-year return: 2,038% Closing price June 8, 2020: $10.51 Closing price June 4, 2020: $193.81 5-year return: 1,744% Closing price June 8, 2020: $6.57 Closing price June 4, 2020: $119.90 5-year return: 1,725% Closing price June 8, 2020: $5.35 Closing price June 4, 2020: $91.66 5-year return: 1,613% Closing price June 8, 2020: $2.71 Closing price June 4, 2020: $46.16 5-year return: 1,603% Closing price June 8, 2020: $10.37 Closing price June 4, 2020: $122.82 5-year return: 1,084% More From GOBankingRates 3 Luxury SUVs That Will Have Massive Price Drops in Summer 2025 8 Common Mistakes Retirees Make With Their Social Security Checks 10 Cars That Outlast the Average Vehicle This article originally appeared on See the Incredible Returns If You Invested in 10 of the Top Performing Stocks Over the Last 5 Years (Including GameStop)
